Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Clinical Study of Immunotherapy With Personalized Synthetic Vaccines in Patients With Triple Negative Breast Cancer

NCT04105582 is registered in ClinicalTrials.gov with Universidad Nacional de Colombia as lead sponsor.

NCT NCT04105582
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04105582 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Clinical Study of Immunotherapy With Personalized Synthetic Vaccines in Patients With Triple Negative Breast Cancer
Lead sponsor
Universidad Nacional de Colombia
Phase
Phase 1
Overall status
Completed
Start date
August 1, 2019
Completion date
February 1, 2022
Enrollment
5 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, triple negative breast cancer